Madrigal Pharmaceuticals, Inc. MDGL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

2/7 Pass

SharesGrow Intrinsic Value

Madrigal Pharmaceuticals, Inc. (MDGL) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 BAY CITY CAPITAL LLC 2,310,521 주 보유. 기타 주요 보유자에는 Kovner Bruce 및 Taub Rebecca.

지난 12개월간 내부자는 30 건의 거래를 수행 MDGL 주식 — 13 건 매수 (평가액 $20.93M) 및 12 건 매도 (평가액 $4.63M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

MDGL 내부자 보유 현황

최대 보유자

BAY CITY CAPITAL LLC

2,310,521 주

매수 (12개월)

$20.93M 평가액

매도 (12개월)

$4.63M 평가액

12개월 거래 활동

매수 43%

매도 40%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Bay City Capital Llc	10 Percent Owner	2,310,521	2020-12-01	100%
2	Kovner Bruce	10 Percent Owner	837,021	2015-12-08	36%
3	Taub Rebecca	Director	452,213	2026-03-06	20%
4	Vukovic Vojo	SVP, Chief Medical Officer	132,300	2015-10-06	6%
5	Mcmahon Arthur	SVP, Human Resources	126,768	2015-03-04	5%
6	Whitaker Anne Clem	President and CEO	100,000	2015-03-04	4%
7	Ramachandra Sumant	President, R&d	75,000	2013-03-13	3%
8	Singh Amar	Sr. VP, Chief Business Officer	73,505	2013-03-07	3%
9	Ehrlich Keith S	VP, Fin. and Admin., CFO	66,985	2014-03-05	3%
10	Schor Chen	Former President and CEO	37,178	2016-07-22	2%
11	Schneebaum Marc R	Chief Financial Officer	32,000	2021-02-23	1%
12	Bernitz Steven B	SVP, Corporate Development	25,000	2013-12-20	1%
13	Kufe Donald W	Director	20,000	2015-07-06	1%
14	Reardon William S	Director	20,000	2015-07-06	1%
15	Wilson Robert N	Director	20,000	2015-07-06	1%
16	Sibold William John	President and CEO	18,743	2026-03-06	1%
17	Morenstein Scott D	Director	17,857	2016-01-05	1%
18	Rieder Wendy E	Former SVP, Gen. Counsel	17,730	2016-07-22	1%
19	Sukhija Remy	Chief Commercial Officer	15,001	2023-01-18	1%
20	Bahcall Safi R	President and CEO	15,000	2014-02-13	1%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-03-06	Kelley Shannon T	General Counsel	정보 매도	360	$431.94	$155.5K
2026-03-04	Kelley Shannon T	General Counsel	RSU 부여	5,022	$434.80	$2.18M
2026-03-06	Huntsman Carole	Chief Commercial Officer	정보 매도	419	$431.94	$180.98K
2026-03-04	Huntsman Carole	Chief Commercial Officer	RSU 부여	4,986	$434.80	$2.17M
2026-03-04	Soergel David	Chief Medical Officer	RSU 부여	5,467	$434.80	$2.38M
2026-03-06	Dier Mardi	EVP and CFO	정보 매도	40	$437.65	$17.51K
2026-03-04	Dier Mardi	EVP and CFO	RSU 부여	6,519	$434.80	$2.83M
2026-03-06	Sibold William John	President and CEO	정보 매도	1,663	$431.94	$718.32K
2026-03-04	Sibold William John	President and CEO	RSU 부여	18,743	$434.80	$8.15M
2026-03-06	Taub Rebecca	Director	정보 매도	491	$431.94	$212.08K
2026-03-02	Dier Mardi	EVP and CFO	정보 매도	1,183	$427.21	$505.39K
2026-02-23	Levy Richard S	Director	옵션 행사 (매도)	2,500	$7.36	$18.4K
2026-01-26	Huntsman Carole	Chief Commercial Officer	정보 매도	570	$494.59	$281.92K
2026-01-26	Sibold William John	President and CEO	정보 매도	1,577	$492.42	$776.55K
2026-01-26	Levy Richard S	Director	옵션 행사 (매도)	4,000	$16.46	$65.84K
2026-01-26	Taub Rebecca	Director	정보 매도	647	$492.42	$318.6K
2026-01-15	Thakkar Rita	Chief Accounting Officer	RSU 부여	1,826	$495.88	$905.48K
2026-01-12	Thakkar Rita	Officer	알 수 없음	-	-	-
2026-01-20	Kelley Shannon T	General Counsel	정보 매도	429	$501.40	$215.1K
2026-01-20	Taub Rebecca	Director	정보 매도	2,238	$490.77	$1.1M
2026-01-09	Taub Rebecca	Director	정보 매도	271	$534.18	$144.76K
2026-01-09	Friedman Paul A	Director	옵션 행사 (매도)	24,520	$15.80	$387.42K
2025-06-20	Daly James M	Director	RSU 부여	1,290	$285.73	$368.59K
2025-06-20	Levy Richard S	Director	RSU 부여	1,290	$285.73	$368.59K
2025-06-20	Fouse Jacqualyn A	Director	RSU 부여	366	$285.73	$104.58K